{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:55:34Z","timestamp":1794614134727,"version":"4.9.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R24 DK110499-01A1"],"award-info":[{"award-number":["R24 DK110499-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL008633-36"],"award-info":[{"award-number":["T32HL008633-36"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1K23DK125838"],"award-info":[{"award-number":["1K23DK125838"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35 CA253185"],"award-info":[{"award-number":["R35 CA253185"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007827","name":"American College of Gastroenterology","doi-asserted-by":"publisher","award":["Pilot Award"],"award-info":[{"award-number":["Pilot Award"]}],"id":[{"id":"10.13039\/100007827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009560","name":"American Gastroenterological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation (DDCF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Linde Family Foundation Novartis Institute for Biomedical Research","id":[{"id":"https:\/\/ror.org\/053gv2m95","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pfizer Ulcerative Colitis Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1038\/s41591-023-02217-7","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T12:03:30Z","timestamp":1677153810000},"page":"700-709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":177,"title":["Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease"],"prefix":"10.1038","volume":"29","author":[{"given":"Raaj S.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8607-1787","authenticated-orcid":false,"given":"Jared R.","family":"Mayers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2768-2975","authenticated-orcid":false,"given":"Yancong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrisha","family":"Bhosle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-5166","authenticated-orcid":false,"given":"Nathaniel R.","family":"Glasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5436-4219","authenticated-orcid":false,"given":"Long H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sena","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobyn","family":"Branck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6037-9345","authenticated-orcid":false,"given":"Kijun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-3946","authenticated-orcid":false,"given":"Julian Avila","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0646-2102","authenticated-orcid":false,"given":"Hyuk-Soo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-9245","authenticated-orcid":false,"given":"Clary","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0824-5929","authenticated-orcid":false,"given":"Sirano","family":"Dhe-Paganon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin N.","family":"Ananthakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8798-7068","authenticated-orcid":false,"given":"Eric A.","family":"Franzosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5985-5714","authenticated-orcid":false,"given":"Emily P.","family":"Balskus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1110-0096","authenticated-orcid":false,"given":"Curtis","family":"Huttenhower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"2217_CR1","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2019.07.045","volume":"178","author":"DR Plichta","year":"2019","unstructured":"Plichta, D. R., Graham, D. B., Subramanian, S. & Xavier, R. J. Therapeutic opportunities in inflammatory bowel disease: mechanistic dissection of host\u2013microbiome relationships. Cell 178, 1041\u20131056 (2019).","journal-title":"Cell"},{"key":"2217_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1586\/ecp.12.2","volume":"5","author":"M Ham","year":"2012","unstructured":"Ham, M. & Moss, A. C. Mesalamine in the treatment and maintenance of remission of ulcerative colitis. Expert Rev. Clin. Pharmacol. 5, 113\u2013123 (2012).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"2217_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/2050640615580228","volume":"3","author":"T Klag","year":"2015","unstructured":"Klag, T., Stange, E. F. & Wehkamp, J. Management of Crohn\u2019s disease\u2014are guidelines transferred to clinical practice?. United European Gastroenterol. J. 3, 371\u2013380 (2015).","journal-title":"United European Gastroenterol. J."},{"key":"2217_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/ajg.2011.67","volume":"106","author":"AC Ford","year":"2011","unstructured":"Ford, A. C. et al. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am. J. Gastroenterol. 106, 601\u2013616 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"2217_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ajg.2011.71","volume":"106","author":"AC Ford","year":"2011","unstructured":"Ford, A. C. et al. Efficacy of 5-aminosalicylates in Crohn\u2019s disease: systematic review and meta-analysis. Am. J. Gastroenterol. 106, 617\u2013629 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"2217_CR6","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","volume":"181","author":"B Javdan","year":"2020","unstructured":"Javdan, B. et al. Personalized mapping of drug metabolism by the human gut microbiome. Cell 181, 1661\u20131679 (2020).","journal-title":"Cell"},{"key":"2217_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","volume":"570","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R. & Goodman, A. L. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570, 462\u2013467 (2019).","journal-title":"Nature"},{"key":"2217_CR8","doi-asserted-by":"publisher","first-page":"eaag2770","DOI":"10.1126\/science.aag2770","volume":"356","author":"N Koppel","year":"2017","unstructured":"Koppel, N., Maini Rekdal, V. & Balskus, E. P. Chemical transformation of xenobiotics by the human gut microbiota. Science 356, eaag2770 (2017).","journal-title":"Science"},{"key":"2217_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41586-021-04091-0","volume":"600","author":"J Balaich","year":"2021","unstructured":"Balaich, J. et al. The human microbiome encodes resistance to the antidiabetic drug acarbose. Nature 600, 110\u2013115 (2021).","journal-title":"Nature"},{"key":"2217_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.1235872","volume":"341","author":"HJ Haiser","year":"2013","unstructured":"Haiser, H. J. et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341, 295\u2013298 (2013).","journal-title":"Science"},{"key":"2217_CR11","doi-asserted-by":"publisher","first-page":"eaau6323","DOI":"10.1126\/science.aau6323","volume":"364","author":"VM Rekdal","year":"2019","unstructured":"Rekdal, V. M., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J. & Balskus, E. P. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science 364, eaau6323 (2019).","journal-title":"Science"},{"key":"2217_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4161\/gmic.27915","volume":"5","author":"HJ Haiser","year":"2014","unstructured":"Haiser, H. J., Seim, K. L., Balskus, E. P. & Turnbaugh, P. J. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes 5, 233\u2013238 (2014).","journal-title":"Gut Microbes"},{"key":"2217_CR13","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.chom.2021.06.019","volume":"29","author":"JWJ Lee","year":"2021","unstructured":"Lee, J. W. J. et al. Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease. Cell Host Microbe 29, 1294\u20131304.e4 (2021).","journal-title":"Cell Host Microbe"},{"key":"2217_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41586-021-04177-9","volume":"600","author":"SK Forslund","year":"2021","unstructured":"Forslund, S. K. et al. Combinatorial, additive and dose-dependent drug\u2013microbiome associations. Nature 600, 500\u2013505 (2021).","journal-title":"Nature"},{"key":"2217_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/BF01740669","volume":"43","author":"RA van Hogezand","year":"1992","unstructured":"van Hogezand, R. A. et al. Bacterial acetylation of 5-aminosalicylic acid in faecal suspensions cultured under aerobic and anaerobic conditions. Eur. J. Clin. Pharmacol. 43, 189\u2013192 (1992).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2217_CR16","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1016\/0006-2952(87)90034-7","volume":"36","author":"BJ Dull","year":"1987","unstructured":"Dull, B. J., Salata, K. & Goldman, P. Role of the intestinal flora in the acetylation of sulfasalazine metabolites. Biochem. Pharmacol. 36, 3772\u20133774 (1987).","journal-title":"Biochem. Pharmacol."},{"key":"2217_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2036.1988.tb00668.x","volume":"2","author":"RA van Hogezand","year":"1988","unstructured":"van Hogezand, R. A. et al. Double-blind comparison of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid suppositories in patients with idiopathic proctitis. Aliment Pharmacol. Ther. 2, 33\u201340 (1988).","journal-title":"Aliment Pharmacol. Ther."},{"key":"2217_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1365-2036.2003.01408.x","volume":"17","author":"WJ Sandborn","year":"2003","unstructured":"Sandborn, W. J. & Hanauer, S. B. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis. Aliment Pharmacol. Ther. 17, 29\u201342 (2003).","journal-title":"Aliment Pharmacol. Ther."},{"key":"2217_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/gut.33.10.1343","volume":"33","author":"A Ireland","year":"1992","unstructured":"Ireland, A., Priddle, J. D. & Jewell, D. P. Comparison of 5-aminosalicylic acid and N-acetylaminosalicylic acid uptake by the isolated human colonic epithelial cell. Gut 33, 1343\u20131347 (1992).","journal-title":"Gut"},{"key":"2217_CR20","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1128\/JB.183.11.3417-3427.2001","volume":"183","author":"C Delom\u00e9nie","year":"2001","unstructured":"Delom\u00e9nie, C. et al. Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid. J. Bacteriol. 183, 3417\u20133427 (2001).","journal-title":"J. Bacteriol."},{"key":"2217_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1042\/BJ20041330","volume":"385","author":"IM Westwood","year":"2005","unstructured":"Westwood, I. M. et al. Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase. Biochem. J 385, 605\u2013612 (2005).","journal-title":"Biochem. J"},{"key":"2217_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655 (2019).","journal-title":"Nature"},{"key":"2217_CR23","doi-asserted-by":"publisher","first-page":"e65088","DOI":"10.7554\/eLife.65088","volume":"10","author":"F Beghini","year":"2021","unstructured":"Beghini, F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife 10, e65088 (2021).","journal-title":"eLife"},{"key":"2217_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jclinepi.2017.10.013","volume":"94","author":"JD Hafferty","year":"2018","unstructured":"Hafferty, J. D. et al. Self-reported medication use validated through record linkage to national prescribing data. J. Clin. Epidemiol. 94, 132\u2013142 (2018).","journal-title":"J. Clin. Epidemiol."},{"key":"2217_CR25","first-page":"CD003715","volume":"9","author":"AK Akobeng","year":"2016","unstructured":"Akobeng, A. K., Zhang, D., Gordon, M. & MacDonald, J. K. Oral 5\u2010aminosalicylic acid for maintenance of medically\u2010induced remission in Crohn\u2019s disease. Cochrane Database Syst. Rev. 9, CD003715 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2217_CR26","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1038\/ismej.2013.123","volume":"7","author":"IA Neshich","year":"2013","unstructured":"Neshich, I. A., Kiyota, E. & Arruda, P. Genome-wide analysis of lysine catabolism in bacteria reveals new connections with osmotic stress resistance. ISME J. 7, 2400\u20132410 (2013).","journal-title":"ISME J."},{"key":"2217_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1042\/BJ20061645","volume":"404","author":"DR Sell","year":"2007","unstructured":"Sell, D. R., Strauch, C. M., Shen, W. & Monnier, V. M. 2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis. Biochem. J. 404, 269\u2013277 (2007).","journal-title":"Biochem. J."},{"key":"2217_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/177328a0","volume":"177","author":"I Harary","year":"1956","unstructured":"Harary, I. Bacterial degradation of nicotinic acid. Nature 177, 328\u2013329 (1956).","journal-title":"Nature"},{"key":"2217_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.15252\/emmm.201606987","volume":"9","author":"J Li","year":"2017","unstructured":"Li, J. et al. Niacin ameliorates ulcerative colitis via prostaglandin D2\u2010mediated D prostanoid receptor 1 activation. EMBO Mol. Med. 9, 571\u2013588 (2017).","journal-title":"EMBO Mol. Med."},{"key":"2217_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","volume":"4","author":"EA Franzosa","year":"2019","unstructured":"Franzosa, E. A. et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat. Microbiol. 4, 293 (2019).","journal-title":"Nat. Microbiol."},{"key":"2217_CR31","doi-asserted-by":"publisher","first-page":"i34","DOI":"10.1093\/bioinformatics\/btab327","volume":"37","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Thompson, K. N., Huttenhower, C. & Franzosa, E. A. Statistical approaches for differential expression analysis in metatranscriptomics. Bioinformatics 37, i34\u2013i41 (2021).","journal-title":"Bioinformatics"},{"key":"2217_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/1097-0134(20001001)41:1<98::AID-PROT120>3.0.CO;2-S","volume":"41","author":"D Devos","year":"2000","unstructured":"Devos, D. & Valencia, A. Practical limits of function prediction. Proteins 41, 98\u2013107 (2000).","journal-title":"Proteins"},{"key":"2217_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-5313-6","volume":"19","author":"CB Fitzgerald","year":"2018","unstructured":"Fitzgerald, C. B. et al. Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa. BMC Genomics 19, 931 (2018).","journal-title":"BMC Genomics"},{"key":"2217_CR34","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.20041948","volume":"201","author":"C Rousseaux","year":"2005","unstructured":"Rousseaux, C. et al. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator\u2013activated receptor-\u03b3. J. Exp. Med. 201, 1205\u20131215 (2005).","journal-title":"J. Exp. Med."},{"key":"2217_CR35","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1006\/jmbi.2000.3638","volume":"297","author":"Y Modis","year":"2000","unstructured":"Modis, Y. & Wierenga, R. K. Crystallographic analysis of the reaction pathway of Zoogloea ramigera biosynthetic thiolase. J. Mol. Biol. 297, 1171\u20131182 (2000).","journal-title":"J. Mol. Biol."},{"key":"2217_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9410","volume":"6","author":"S Kim","year":"2015","unstructured":"Kim, S. et al. Redox-switch regulatory mechanism of thiolase from Clostridium acetobutylicum. Nat. Commun. 6, 8410 (2015).","journal-title":"Nat. Commun."},{"key":"2217_CR37","doi-asserted-by":"crossref","unstructured":"Mathieu, M. et al. The 1.8 \u00c5 crystal structure of the dimeric peroxisomal 3-ketoacyl-CoA thiolase of Saccharomyces cerevisiae: implications for substrate binding and reaction mechanism. J. Mol. Biol. 273, 714\u2013728 (1997).","DOI":"10.1006\/jmbi.1997.1331"},{"key":"2217_CR38","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/S0140-6736(18)32592-3","volume":"393","author":"JS Hyams","year":"2019","unstructured":"Hyams, J. S. et al. Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study. Lancet 393, 1708\u20131720 (2019).","journal-title":"Lancet"},{"key":"2217_CR39","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11894-012-0302-4","volume":"15","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan, A. N. Environmental triggers for inflammatory bowel disease. Curr. Gastroenterol. Rep. 15, 302 (2013).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"2217_CR40","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1111\/j.1572-0241.2002.05838.x","volume":"97","author":"E Ricart","year":"2002","unstructured":"Ricart, E. et al. N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis. Am. J. Gastroenterol. 97, 1763\u20131768 (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"2217_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60467-8","volume":"10","author":"J Yee","year":"2020","unstructured":"Yee, J. et al. The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis. Sci. Rep. 10, 3658 (2020).","journal-title":"Sci. Rep."},{"key":"2217_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00228-008-0550-2","volume":"65","author":"H L\u00fcck","year":"2009","unstructured":"L\u00fcck, H., Kinzig, M., Jetter, A., Fuhr, U. & S\u00f6rgel, F. Mesalazine pharmacokinetics and NAT2 phenotype. Eur. J. Clin. Pharmacol. 65, 47\u201354 (2009).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2217_CR43","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cgh.2010.03.022","volume":"8","author":"CY Ha","year":"2010","unstructured":"Ha, C. Y., Newberry, R. D., Stone, C. D. & Ciorba, M. A. Patients with late adult onset ulcerative colitis have better outcomes than those with early onset disease. Clin. Gastroenterol. Hepatol. 8, 682\u2013687 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2217_CR44","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.bbamcr.2010.01.022","volume":"1803","author":"DHEW Huberts","year":"2010","unstructured":"Huberts, D. H. E. W. & van der Klei, I. J. Moonlighting proteins: an intriguing mode of multitasking. Biochim. Biophys. Acta 1803, 520\u2013525 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"2217_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.bbrc.2020.09.048","volume":"533","author":"J Hong","year":"2020","unstructured":"Hong, J., Park, W., Seo, H., Kim, I.-K. & Kim, K.-J. Crystal structure of an acetyl-CoA acetyltransferase from PHB producing bacterium Bacillus cereus ATCC 14579. Biochem. Biophys. Res. Commun. 533, 442\u2013448 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2217_CR46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623\u2013628 (2018).","journal-title":"Nature"},{"key":"2217_CR47","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1126\/science.1191175","volume":"330","author":"BD Wallace","year":"2010","unstructured":"Wallace, B. D. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831\u2013835 (2010).","journal-title":"Science"},{"key":"2217_CR48","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1136\/gut.33.10.1338","volume":"33","author":"M De Vos","year":"1992","unstructured":"De Vos, M. et al. Concentrations of 5-ASA and Ac-5-ASA in human ileocolonic biopsy homogenates after oral 5-ASA preparations. Gut 33, 1338\u20131342 (1992).","journal-title":"Gut"},{"key":"2217_CR49","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/1755-0998.12529","volume":"16","author":"BK Lohman","year":"2016","unstructured":"Lohman, B. K., Weber, J. N. & Bolnick, D. I. Evaluation of TagSeq, a reliable low-cost alternative for RNAseq. Mol. Ecol. Resour. 16, 1315\u20131321 (2016).","journal-title":"Mol. Ecol. Resour."},{"key":"2217_CR50","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/bioinformatics\/btu739","volume":"31","author":"BE Suzek","year":"2015","unstructured":"Suzek, B. E. et al. UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches. Bioinformatics 31, 926\u2013932 (2015).","journal-title":"Bioinformatics"},{"key":"2217_CR51","first-page":"719","volume":"10","author":"J Oksanen","year":"2007","unstructured":"Oksanen, J. et al. The vegan package. Community ecology package 10, 719 (2007).","journal-title":"Community ecology package"},{"key":"2217_CR52","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2016).","DOI":"10.1007\/978-3-319-24277-4"},{"key":"2217_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41587-019-0375-9","volume":"38","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. Mass spectrometry searches using MASST. Nat. Biotechnol. 38, 23\u201326 (2020).","journal-title":"Nat. Biotechnol."},{"key":"2217_CR54","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/s41596-020-0317-5","volume":"15","author":"AT Aron","year":"2020","unstructured":"Aron, A. T. et al. Reproducible molecular networking of untargeted mass spectrometry data using GNPS. Nat. Protoc. 15, 1954\u20131991 (2020).","journal-title":"Nat. Protoc."},{"key":"2217_CR55","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1053\/j.gastro.2017.02.015","volume":"152","author":"RS Mehta","year":"2017","unstructured":"Mehta, R. S. et al. Dietary patterns and risk of colorectal cancer: analysis by tumor location and molecular subtypes. Gastroenterology 152, 1944\u20131953 (2017).","journal-title":"Gastroenterology"},{"key":"2217_CR56","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41586-020-2896-2","volume":"588","author":"N Bar","year":"2020","unstructured":"Bar, N. et al. A reference map of potential determinants for the human serum metabolome. Nature 588, 135\u2013140 (2020).","journal-title":"Nature"},{"key":"2217_CR57","unstructured":"Groemping, U. & Matthias, L. Package \u2018relaimpo\u2019. Relative Importance of Regressors in Linear Models. https:\/\/cran.r-project.org\/web\/packages\/relaimpo\/relaimpo.pdf (R Foundation for Statstical Computing, 2021)."},{"key":"2217_CR58","doi-asserted-by":"crossref","unstructured":"Bustion, A., Agrawal, A., Turnbaugh, P. J. & Pollard, K. S. A novel in silico method employs chemical and protein similarity algorithms to accurately identify chemical transformations in the human gut microbiome. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2022.08.02.502504v1 (2022).","DOI":"10.1101\/2022.08.02.502504"},{"key":"2217_CR59","doi-asserted-by":"publisher","first-page":"E2329","DOI":"10.1073\/pnas.1319284111","volume":"111","author":"EA Franzosa","year":"2014","unstructured":"Franzosa, E. A. et al. Relating the metatranscriptome and metagenome of the human gut. Proc. Natl Acad. Sci. USA 111, E2329\u2013E2338 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2217_CR60","unstructured":"Pinheiro, J. et al. Package \u2018nlme\u2019. Linear and Nonlinear Mixed Effects Models, version 3 (2017)."},{"key":"2217_CR61","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chom.2020.05.013","volume":"28","author":"DJ Kenny","year":"2020","unstructured":"Kenny, D. J. et al. Cholesterol metabolism by uncultured human gut bacteria influences host cholesterol level. Cell Host Microbe 28, 245\u2013257 (2020).","journal-title":"Cell Host Microbe"},{"key":"2217_CR62","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"The UniProt Consortium.","year":"2021","unstructured":"The UniProt Consortium. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 49, D480\u2013D489 (2021).","journal-title":"Nucleic Acids Res."},{"key":"2217_CR63","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","volume":"22","author":"JD Thompson","year":"1994","unstructured":"Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673\u20134680 (1994).","journal-title":"Nucleic Acids Res."},{"key":"2217_CR64","doi-asserted-by":"publisher","first-page":"10915","DOI":"10.1073\/pnas.89.22.10915","volume":"89","author":"S Henikoff","year":"1992","unstructured":"Henikoff, S. & Henikoff, J. G. Amino acid substitution matrices from protein blocks. Proc. Natl Acad. Sci. USA 89, 10915\u201310919 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2217_CR65","doi-asserted-by":"publisher","first-page":"D211","DOI":"10.1093\/nar\/gkn785","volume":"37","author":"S Hunter","year":"2009","unstructured":"Hunter, S. et al. InterPro: the integrative protein signature database. Nucleic Acids Res. 37, D211\u2013D215 (2009).","journal-title":"Nucleic Acids Res."},{"key":"2217_CR66","doi-asserted-by":"publisher","first-page":"D73","DOI":"10.1093\/nar\/gkv1226","volume":"44","author":"PA Kitts","year":"2016","unstructured":"Kitts, P. A. et al. Assembly: a resource for assembled genomes at NCBI. Nucleic Acids Res. 44, D73\u2013D80 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2217_CR67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nmeth.3176","volume":"12","author":"B Buchfink","year":"2015","unstructured":"Buchfink, B., Xie, C. & Huson, D. H. Fast and sensitive protein alignment using DIAMOND. Nat. Methods 12, 59\u201360 (2015).","journal-title":"Nat. Methods"},{"key":"2217_CR68","doi-asserted-by":"publisher","first-page":"otab046","DOI":"10.1093\/crocol\/otab046","volume":"360","author":"GK Dawwas","year":"2021","unstructured":"Dawwas, G. K. et al. Prevalence and factors associated with fecal urgency among patients with ulcerative colitis and Crohn\u2019s disease in the study of a prospective adult research cohort with inflammatory bowel disease. Crohns Colitis 360, otab046 (2021).","journal-title":"Crohns Colitis"},{"key":"2217_CR69","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/ibd\/izab071","volume":"28","author":"LE Raffals","year":"2021","unstructured":"Raffals, L. E. et al. The development and initial findings of a Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD). Inflamm. Bowel Dis. 28, 192\u2013199 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"2217_CR70","unstructured":"Carey, V. J., Lumley, T. S., Moler, C. & Ripley, B. Package \u2018gee\u2019. Generalized Estimation Equation Solver. https:\/\/cran.r-project.org\/web\/packages\/gee\/gee.pdf (2022)."},{"key":"2217_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Soft. 36, 1\u201348 (2010).","journal-title":"J. Stat. Soft."},{"key":"2217_CR72","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0140-6736(05)67137-1","volume":"366","author":"M Garc\u00eda-Closas","year":"2005","unstructured":"Garc\u00eda-Closas, M. et al. NAT2 slow acetylation and GSTM1 null genotypes increase bladder cancer risk: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366, 649\u2013659 (2005).","journal-title":"Lancet"},{"key":"2217_CR73","doi-asserted-by":"publisher","first-page":"e0186200","DOI":"10.1371\/journal.pone.0186200","volume":"12","author":"SL Chan","year":"2017","unstructured":"Chan, S. L. et al. Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients. PLoS ONE 12, e0186200 (2017).","journal-title":"PLoS ONE"},{"key":"2217_CR74","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/FPC.0b013e3283493a23","volume":"21","author":"S Selinski","year":"2011","unstructured":"Selinski, S. et al. Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype. Pharmacogenet. Genomics 21, 673\u2013678 (2011).","journal-title":"Pharmacogenet. Genomics"},{"key":"2217_CR75","unstructured":"XDS Program Package. https:\/\/xds.mr.mpg.de\/"},{"key":"2217_CR76","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2217_CR77","unstructured":"Coot. https:\/\/www2.mrc-lmb.cam.ac.uk\/personal\/pemsley\/coot\/"},{"key":"2217_CR78","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"2217_CR79","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/clpt.1989.200","volume":"46","author":"RW Ding","year":"1989","unstructured":"Ding, R. W. et al. Pharmacokinetics of nicotinic acid\u2014salicylic acid interaction. Clin. Pharmacol. Ther. 46, 642\u2013647 (1989).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2217_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10034-5","volume":"7","author":"ML Santoru","year":"2017","unstructured":"Santoru, M. L. et al. Cross sectional evaluation of the gut\u2013microbiome metabolome axis in an Italian cohort of IBD patients. Sci. Rep. 7, 9523 (2017).","journal-title":"Sci. Rep."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02217-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T10:16:12Z","timestamp":1679480172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02217-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["2217"],"URL":"https:\/\/doi.org\/10.1038\/s41591-023-02217-7","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.H. is a consultant to Zoe, Ltd. and is on the scientific advisory boards of Seres Therapeutics and Empress Therapeutics. A.T.C. has been an investigator on a clinical study supported by Zoe, Ltd. Other authors declare that they have no competing interests. R.S.M., J.R.M., E.P.B., A.T.C. and C.H. filed a provisional patent application (63\/383,269) on 11 November 2022.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}